A Mouse Model of Orotracheal Intubation and Ventilated Lung Ischemia Reperfusion Surgery
September 9th, 2022
3.8K views
A mouse surgical model to create left lung ischemia reperfusion (IR) injury while maintaining ventilation and avoiding hypoxia.
Overview
This article presents a mouse surgical model designed to create left lung ischemia reperfusion (IR) injury while maintaining ventilation and avoiding hypoxia. The model is useful for studying lung-specific pathophysiology related to various conditions such as lung transplantation and pulmonary embolism.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Pathophysiology
Background
- The model minimizes inflammatory contributions from atelectasis and mechanical ventilation.
- It maintains an intact in vivo circulatory immune system.
- Longer-term studies can be conducted using this model.
- Insights into the regulation of sterile inflammation in the lung can be gained.
Purpose of Study
- To investigate lung injury mechanisms following hemorrhagic trauma with resuscitation.
- To provide a platform for studying lung transplantation and pulmonary embolism.
- To explore the control and regulation of sterile inflammation in lung tissue.
Methods Used
- Ventilated lung ischemia-reperfusion surgery technique.
- Microsurgical techniques requiring extensive practice.
- Careful organization and planning prior to surgery.
- In vivo studies to assess lung pathophysiology.
Main Results
- The model effectively simulates ischemia-reperfusion injury.
- Inflammatory responses are minimized compared to traditional methods.
- Long-term observations are feasible with this surgical approach.
- Insights into lung-specific inflammatory processes were obtained.
Conclusions
- This model is a valuable tool for studying lung injuries.
- It allows for the investigation of complex lung pathophysiology.
- Future studies can build on the findings related to sterile inflammation.
Frequently Asked Questions
What is ischemia-reperfusion injury?
Ischemia-reperfusion injury occurs when blood supply returns to tissue after a period of ischemia, causing inflammation and oxidative damage.
Why is ventilation important in this model?
Ventilation is crucial to maintain oxygen levels and prevent hypoxia during the surgical procedure.
How does this model differ from traditional methods?
This model minimizes inflammatory responses associated with atelectasis and mechanical ventilation, allowing for clearer insights into lung injury mechanisms.
What are the implications of this research?
The findings can lead to better understanding and treatment strategies for lung injuries related to various medical conditions.
Is this model suitable for long-term studies?
Yes, the model allows for longer-term studies due to its design that maintains an intact circulatory immune system.
What skills are required to perform the surgery?
The microsurgical technique requires extensive practice and careful planning to ensure successful outcomes.
Executive Industry Relevance
Reversible orotracheal intubation and ventilated lung ischemia reperfusion in mice enables precise modeling of lung-specific sterile inflammation and injury, directly relevant to transplantation, embolism, and trauma research. This model supports mechanistic de-risking by isolating ischemia-reperfusion effects from confounding hypoxia or atelectasis, enhancing predictive confidence for translational lung injury studies. Its reproducibility and survival rates position it as a robust platform for early discovery and preclinical validation in respiratory drug development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of sterile inflammatory pathways in a controlled, ventilated lung environment.
- Supports functional target validation by isolating ischemia-reperfusion injury from secondary insults.
- Facilitates mechanistic de-risking for candidate targets implicated in lung injury and repair.
- Provides a platform for stepwise evaluation of immune cell trafficking and activation.
Screening & Assay Development
- Prepares validated in vivo models for downstream compound screening targeting lung inflammation.
- Standardizes injury induction and readouts, supporting reproducibility across studies.
- Enables quantitative assessment of neutrophil infiltration and inflammatory markers post-injury.
- Supports scalability for comparative studies across mouse strains or interventions.
Translational & Preclinical Research
- Aligns with disease-relevant mechanisms observed in transplantation, embolism, and trauma settings.
- Permits modeling of two-hit scenarios, such as infection following sterile injury, for translational biomarker discovery.
- Enables continuity from mechanistic discovery to preclinical efficacy and safety evaluation.
- Supports risk-adjusted advancement of anti-inflammatory or immunomodulatory candidates.
Pipeline & Workflow Integration
This model integrates into the discovery-to-preclinical continuum, bridging mechanistic studies and translational validation for lung injury therapeutics.
- Discovery Biology: Supports hypothesis testing on sterile inflammation and immune cell dynamics in the lung.
- Screening: Provides reproducible, quantitative outputs for evaluating candidate interventions.
- Analytics: Enables measurement of neutrophil infiltration and histopathological changes for comparative analysis.
- Translational Research: Models clinically relevant injury and infection sequences for biomarker alignment.
- Enterprise Reuse: Offers a reusable, standardized platform for diverse lung injury and repair studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in lung injury research.
- Operational Value: Delivers standardized, reproducible, and scalable in vivo workflows.
- Strategic Value: Improves go/no-go decisions and capital efficiency by clarifying biological risk early.
- Portfolio Impact: Enables risk-adjusted prioritization of respiratory and anti-inflammatory assets.
Implementation Considerations
- Requires advanced microsurgical expertise and extensive hands-on training.
- Demands specialized instrumentation for intubation, thoracotomy, and ventilatory support.
- Necessitates rigorous cross-team standardization for reproducibility and data comparability.
- Adaptation across mouse strains may reveal strain-specific inflammatory responses.
- Technical complexity and risk of surgical complications must be managed during onboarding.
Biopharma FAQs
Why does null hypothesis testing matter for neutrophil infiltration analysis?
Null hypothesis testing enables objective assessment of whether observed neutrophil infiltration post-ischemia reperfusion is statistically significant, supporting robust target validation and reducing false positives in early discovery.
How does independent variable isolation in ventilated IR surgery support discovery?
Isolating ischemia-reperfusion as the independent variable, while maintaining ventilation, allows teams to attribute downstream inflammatory responses specifically to IR injury, clarifying mechanistic pathways for target identification.
What do quantitative measurements of lung inflammation enable in this model?
Quantitative assessment of neutrophil infiltration and histopathology enables comparative evaluation of interventions, supports dose-response studies, and informs go/no-go decisions for candidate therapeutics.
Why are replication requirements critical for cross-functional lung IR studies?
Replication ensures that findings on lung injury and immune response are reproducible across operators and strains, facilitating cross-functional collaboration and increasing confidence in translational relevance.
What statistical analysis capabilities are needed before implementing neutrophil readouts?
Teams require statistical tools for group comparisons, significance testing, and variance analysis to interpret neutrophil infiltration data, ensuring reliable conclusions for portfolio advancement.
